AstraZeneca investing $50B in US, Trump calls it an ‘honor’
British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and President Trump calling it an “honor.” The company announced the investment on Monday, saying it would invest $50 billion into the country by 2030 to build on “America’s…
